Cargando…

Diagnosing pancreatic neuroendocrine tumors in patients with multiple endocrine neoplasia type 1 in daily practice

BACKGROUND: In multiple endocrine neoplasia type 1 (MEN1), pancreatic neuroendocrine tumors (PanNETs) have a high prevalence and represent the main cause of death. This study aimed to assess the diagnostic accuracy of the currently used conventional pancreatic imaging techniques and the added value...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Beek, Dirk-Jan, Pieterman, Carolina R. C., Wessels, Frank J., van de Ven, Annenienke C., de Herder, Wouter W., Dekkers, Olaf M., Zandee, Wouter T., Drent, Madeleine L., Bisschop, Peter H., Havekes, Bas, Borel Rinkes, Inne H. M., Vriens, Menno R., Valk, Gerlof D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9585192/ https://www.ncbi.nlm.nih.gov/pubmed/36277719 http://dx.doi.org/10.3389/fendo.2022.926491

Ejemplares similares

Prognostic factors and survival in MEN1 patients with gastrinomas: Results from the DutchMEN study group (DMSG)
por: van Beek, Dirk‐Jan, et al.
Publicado: (2019)

Postoperative Complications After Prophylactic Thyroidectomy for Very Young Patients With Multiple Endocrine Neoplasia Type 2: Retrospective Cohort Analysis
por: Kluijfhout, Wouter P., et al.
Publicado: (2015)

‘Quality in, quality out’, a stepwise approach to evidence-based medicine for rare diseases promoted by multiple endocrine neoplasia type 1
por: van Beek, Dirk-Jan, et al.
Publicado: (2018)

Differences between sporadic and MEN related primary hyperparathyroidism; clinical expression, preoperative workup, operative strategy and follow-up
por: Twigt, Bas A, et al.
Publicado: (2013)

MEN1 redefined, a clinical comparison of mutation-positive and mutation-negative patients
por: de Laat, Joanne M., et al.
Publicado: (2016)

(18)F-Fluorocholine PET–CT enables minimal invasive parathyroidectomy in patients with negative sestamibi SPECT–CT and ultrasound: A case report
por: Kluijfhout, Wouter P., et al.
Publicado: (2015)

Detection of Synchronous Parathyroid Adenoma and Breast Cancer with (18)F-Fluorocholine PET-CT
por: Vorselaars, Wessel MCM, et al.
Publicado: (2015)

A simplified primary aldosteronism surgical outcome score is a useful prediction model when target organ damage is unknown – Retrospective cohort study
por: Suurd, Diederik P.D., et al.
Publicado: (2021)

Update on the clinical management of multiple endocrine neoplasia type 1
por: Pieterman, Carolina R. C., et al.
Publicado: (2022)

Hypercalcemia in patients with bipolar disorder treated with lithium: a cross-sectional study
por: Twigt, Bas A, et al.
Publicado: (2013)

Assessing Outcomes After Adrenalectomy for Primary Aldosteronism – Early is Accurate: Retrospective Cohort Study
por: Suurd, Diederik P.D., et al.
Publicado: (2022)

Surgery for multiple endocrine neoplasia type 1‐related insulinoma: long‐term outcomes in a large international cohort
por: van Beek, D. J., et al.
Publicado: (2020)

Factors Predicting Outcome of Total Thyroidectomy in Young Patients with Multiple Endocrine Neoplasia Type 2: A Nationwide Long-Term Follow-up Study
por: Schreinemakers, Jennifer M. J., et al.
Publicado: (2010)

ASO Author Reflections: Severe Morbidity After Major Surgery in Patients with MEN1
por: van Beek, Dirk-Jan, et al.
Publicado: (2021)

Complications After Major Surgery for Duodenopancreatic Neuroendocrine Tumors in Patients with MEN1: Results from a Nationwide Cohort
por: van Beek, Dirk-Jan, et al.
Publicado: (2021)

(68)Ga-PSMA PET/CT in radioactive iodine-refractory differentiated thyroid cancer and first treatment results with (177)Lu-PSMA-617
por: de Vries, Lisa H., et al.
Publicado: (2020)

A Blood-Based Polyamine Signature Associated With Disease Progression in Patients With Multiple Endocrine Neoplasia Type 1-Related Duodenopancreatic Neuroendocrine Tumors
por: Fahrmann, Johannes F, et al.
Publicado: (2021)

Diagnosing Nonfunctional Pancreatic NETs in MEN1: The Evidence Base
por: van Treijen, Mark J C, et al.
Publicado: (2018)

Timely diagnosis of multiple endocrine neoplasia 2B by identification of intestinal ganglioneuromatosis: a case series
por: van den Broek, Medard F. M., et al.
Publicado: (2021)

Diagnostic Utility of Menin Immunohistochemistry in Patients With Multiple Endocrine Neoplasia Type 1 Syndrome
por: Verschuur, Anna Vera D., et al.
Publicado: (2023)

Expression of HIF-1α in medullary thyroid cancer identifies a subgroup with poor prognosis
por: Lodewijk, Lutske, et al.
Publicado: (2017)

Unilateral Clearance for Primary Hyperparathyroidism in Selected Patients with Multiple Endocrine Neoplasia Type 1
por: Kluijfhout, Wouter P., et al.
Publicado: (2016)

Growth Patterns in Children With Multiple Endocrine Neoplasia Type 2B: Small Stature in Childhood
por: van den Broek, Medard F M, et al.
Publicado: (2021)

Outcomes of Minimally Invasive Thyroid Surgery – A Systematic Review and Meta-Analysis
por: de Vries, Lisa H., et al.
Publicado: (2021)

Efficacy and Complications of Nasojejunal, Jejunostomy and Parenteral Feeding After Pancreaticoduodenectomy
por: Gerritsen, Arja, et al.
Publicado: (2012)

Children with multiple endocrine neoplasia type 2B: Not tall and marfanoid, but short with normal body proportions
por: van den Broek, Medard F. M., et al.
Publicado: (2021)

Invited Commentary: Overall Survival in Patients with Stage IV Pan-NET Eligible for Liver Transplantation
por: Borel Rinkes, Inne H. M.
Publicado: (2022)

Adequate symptom relief justifies hepatic resection for benign disease
por: Fioole, Bram, et al.
Publicado: (2005)

SSTR2A expression in medullary thyroid carcinoma is correlated with longer survival
por: de Vries, Lisa H., et al.
Publicado: (2018)

ALDH1A1 expression is associated with poor differentiation, ‘right-sidedness’ and poor survival in human colorectal cancer
por: van der Waals, Lizet M., et al.
Publicado: (2018)

Fluorodeoxyglucose-positron emission tomography scan-positive recurrent papillary thyroid cancer and the prognosis and implications for surgical management
por: Schreinemakers, Jennifer MJ, et al.
Publicado: (2012)

Liver metastases of neuroendocrine tumours; early reduction of tumour load to improve life expectancy
por: Veenendaal, Liesbeth M, et al.
Publicado: (2006)

Peptide Receptor Radionuclide Therapy With (177)Lu-DOTATATE for Symptomatic Control of Refractory Carcinoid Syndrome
por: Zandee, Wouter T, et al.
Publicado: (2021)

Oncogenic K-Ras Activates p38 to Maintain Colorectal Cancer Cell Proliferation during MEK Inhibition
por: van Houdt, Winan J., et al.
Publicado: (2010)

Response to Letter to the Editor on Robotic Distal Pancreatectomy, a Novel Standard of Care? Benchmark Values for Surgical Outcomes From 16 International Expert Centers
por: Müller, Philip C., et al.
Publicado: (2023)

Not the Number but the Location of Lymph Nodes Matters for Recurrence Rate and Disease-Free Survival in Patients with Differentiated Thyroid Cancer
por: de Meer, S. G. A., et al.
Publicado: (2012)

Precision radiotherapy using MR-linac for pancreatic neuroendocrine tumors in MEN1 patients (PRIME): a protocol for a phase I-II trial, and systematic review on available evidence for radiotherapy of pNETs
por: van Vliembergen, Eline N. M., et al.
Publicado: (2023)

Evolution of the Mesenteric Mass in Small Intestinal Neuroendocrine Tumours
por: Blažević, Anela, et al.
Publicado: (2021)

Blood Transcript Profiling for the Detection of Neuroendocrine Tumors: Results of a Large Independent Validation Study
por: van Treijen, Mark J. C., et al.
Publicado: (2018)

Letter to the Editor From Zandee and Links: “Metastatic Differentiated Thyroid Cancer Survival Is Unaffected by Mode of Preparation for (131)I Administration”
por: Zandee, Wouter T, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_b1of2h0dulvq8ldt1vsps3fpjp